Two human induced pluripotent stem cell (hiPSC) clones, previously reprogrammed by our team [27], were used in this study: one harboring the homozygous GDAP1 nonsense mutation (c.581C>G, p.Ser194*) from a CMT patient, and the other used as control, free from any mutations in this same gene. This evidence concerns the gene GDAP1 and Charcot-Marie-Tooth disease.